Numinus Wellness Inc.

DB:LR23 Stock Report

Market Cap: €6.5m

Numinus Wellness Management

Management criteria checks 3/4

Numinus Wellness' CEO is Payton Nyquvest, appointed in May 2020, has a tenure of 4.42 years. total yearly compensation is CA$565.00K, comprised of 57.5% salary and 42.5% bonuses, including company stock and options. directly owns 2.61% of the company’s shares, worth €169.49K. The average tenure of the management team and the board of directors is 3.1 years and 4 years respectively.

Key information

Payton Nyquvest

Chief executive officer

CA$565.0k

Total compensation

CEO salary percentage57.5%
CEO tenure4.4yrs
CEO ownership2.6%
Management average tenure3.1yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Payton Nyquvest's remuneration changed compared to Numinus Wellness's earnings?
DateTotal CompensationSalaryCompany Earnings
May 31 2024n/an/a

-CA$26m

Feb 29 2024n/an/a

-CA$27m

Nov 30 2023n/an/a

-CA$28m

Aug 31 2023CA$565kCA$325k

-CA$30m

May 31 2023n/an/a

-CA$44m

Feb 28 2023n/an/a

-CA$45m

Nov 30 2022n/an/a

-CA$46m

Aug 31 2022CA$277kCA$277k

-CA$45m

May 31 2022n/an/a

-CA$28m

Feb 28 2022n/an/a

-CA$26m

Nov 30 2021n/an/a

-CA$22m

Aug 31 2021CA$568kCA$274k

-CA$19m

May 31 2021n/an/a

-CA$14m

Feb 28 2021n/an/a

-CA$13m

Nov 30 2020n/an/a

-CA$11m

Aug 31 2020CA$208kCA$205k

-CA$10m

Compensation vs Market: Payton's total compensation ($USD416.28K) is about average for companies of similar size in the German market ($USD499.40K).

Compensation vs Earnings: Payton's compensation has increased whilst the company is unprofitable.

CEO

Payton Nyquvest

4.4yrs

Tenure

CA$565,000

Compensation

Mr. Payton Nyquvest is a Founder of Numinus Wellness Inc. and also serves as its Chief Executive Officer since May 15, 2020 and serves as its Director since May 15, 2020 and serves as its Chairman since 20...

Leadership Team

NamePositionTenureCompensationOwnership
Payton Nyquvest
Founder4.4yrsCA$565.00k2.61%
CA$ 169.5k
Michael Tan
President4.4yrsCA$455.00k0.75%
CA$ 49.0k
Paul Thielking
Chief Science & Medical Officer2.3yrsCA$531.42k0.0092%
CA$ 597.8
Reid Robison
Chief Clinical Officer2.3yrsCA$538.76k0.34%
CA$ 21.8k
Melony Valleau
Interim Chief Financial Officerless than a yearno datano data
Jamie Kokoska
Vice President of Investor Relationsno datano datano data
Paula Hewitt
Senior VPno datano datano data
Ian Noble
Chief Communications Officer3.4yrsno datano data
Danielle Hinan
Vice President Marketing2.9yrsno datano data
Lea Bottoni
Vice President of People & Culture3.3yrsno datano data
Judy Varga
Head of Laboratory Operations3.9yrsno datano data
Jason Lapensee
Senior Vice President of Clinic Operations1.8yrsno data0.0031%
CA$ 201.2

3.1yrs

Average Tenure

51yo

Average Age

Experienced Management: LR23's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Payton Nyquvest
Founder4.4yrsCA$565.00k2.61%
CA$ 169.5k
Michael Tan
President4.4yrsCA$455.00k0.75%
CA$ 49.0k
Larry Timlick
Independent Director5.8yrsCA$40.00k0.18%
CA$ 11.7k
Allen Morishita
Independent Director12.6yrsCA$40.00k0.31%
CA$ 20.0k
Jamie Wheal
Member of General Advisory Counsel4yrsno datano data
Ben Nemtin
Member of General Advisory Counsel4yrsno datano data
Dennis McKenna
Member of General Advisory Counsel4yrsno datano data
Pamela Hadfield
Member of General Advisory Counsel4yrsno datano data
Nichol Bradford
Member of General Advisory Counsel4yrsno datano data
Pam Kryskow
Member of the Clinical Advisory Council3.9yrsno datano data
Gabor Mate
Member of the Clinical Advisory Council3.9yrsno datano data
Zachary Walsh
Member of the Clinical Advisory Council3.9yrsno datano data

4.0yrs

Average Tenure

Experienced Board: LR23's board of directors are considered experienced (4 years average tenure).